Marta Giner Asins, of counsel, joined Norton Rose after practising with several French and international law firms. She regularly defends clients before the French and European authorities and courts, particularly in cases of abuse of dominant position. She has also assisted clients during “dawn raids” conducted by competition authorities and in the procedures challenging such inspections. She has been involved in several French and European merger cases, among which several multi-jurisdictional filings. Marta regularly organises internal training sessions for clients on the main aspects of competition law.
Pharmaceutical Antitrust 2018
Pages: 140
ISBN: 978-1-78915-049-0
* For corporate sales or customer pricing, please fill the form here
This easy-to-use reference guide provides comparative analysis and expert local insight into the field of pharmaceutical antitrust across 19 jurisdictions, covering areas such as: pharmaceutical regulatory law, competition legislation and regulation, review of mergers, anti-competitive agreements and anti-competitive unilateral conduct.
Published in April 2018, this edition contains the following chapters:
Editorial chapters
-
Introduction
- Marta Giner Asins and Yann Anselin, Norton Rose Fulbright LLP
Jurisdictions
- Brazil
- Bulgaria
- Canada
- China
- Finland
- France
- India
- Israel
- Japan
- Korea
- Mexico
- Poland
- Portugal
- Romania
- Spain
- Turkey
- Ukraine
- United Kingdom
- United States
